Significant augmentation of regulatory T cell numbers occurs during the early neonatal period

S Hayakawa1, N Ohno1, S Okada1

  • 1Department of Pediatrics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.

Insights

Neonatal regulatory T cells (Tregs) increase in early infancy to manage immune responses. Activated Tregs, expressing CTLA-4, CCR4, and reduced CCR7, are particularly abundant, helping prevent overactive immunity after birth.

Area of Science:

  • Immunology
  • Neonatal Health

Background:

  • Regulatory T cells (Tregs) are crucial for immune suppression.
  • Neonatal immune system undergoes significant adaptation upon environmental exposure.
  • Understanding Treg dynamics in newborns is vital for immune tolerance.

Purpose of the Study:

  • To investigate the number and phenotype of T regulatory cells (Tregs) during the neonatal period.
  • To characterize Treg subpopulations and their markers in early and late neonatal stages.

Main Methods:

  • Flow cytometry analysis of CD4+ forkhead box protein 3 (FoxP3+) T cells in cord blood (CB) and peripheral blood (PB).
  • Classification of T cells into resting Tregs, activated Tregs, and newly activated T cells.
  • Assessment of T regulatory cell markers like CTLA-4, CCR4, and CCR7.
  • In vitro culture of cord blood cells with CD3 monoclonal antibodies (mAb).

Main Results:

  • Tregs and their subpopulations were significantly increased in the early neonatal period compared to the late period.
  • Activated Tregs (CD45RA- FoxP3high) showed a marked increase in proportion and absolute numbers.
  • Expanded Tregs exhibited increased CTLA-4, upregulated CCR4, and downregulated CCR7 expression.
  • In vitro stimulation led to a significant increase in activated Tregs.

Conclusions:

  • Increased activated Tregs in early neonates play a key role in immune regulation.
  • These Tregs help suppress excessive T cell activation following immediate postnatal antigen exposure.
  • This finding highlights the importance of Tregs in establishing neonatal immune tolerance.